IV’s latest passive vaccine storage device, or Arktek™, as it’s now known, has had a big year so far. The World Health Organization (WHO) and the Centers for Disease Control tagged the Arktek to help make Ebola vaccine trials in Sierra Leone and Guinea possible.
In the PBS NewsHour segment, “Why testing an Ebola vaccine isn’t so easy,” science correspondent Miles O'Brian reports on the challenges of conducting experimental drug trials in Sierra Leone and Liberia. The Deep Freeze Arktek is noted at the 1:30 mark of the video below.
The Arktek is allowing researchers on the ground in Africa to determine the efficacy of Ebola vaccine candidates. An important requirement in keeping the Ebola vaccine effective throughout the trials is keeping the vaccines at appropriate temperatures until being thawed for injection. And these vaccines require unusually low temperatures during storage, transportation, and distribution.Read the full story »